Peter Del Tredici weighs in on ginkgo and memory

Ginkgo products have become a hot commodity in the twenty-first century, but do they actually boost memory?

Return to main article:

High on an upper bookshelf in Peter Del Tredici’s office sits a faded box of organic breakfast cereal called GinkgOs. In large letters, it proclaims: “For Sharp Thinking.” The millions who now take Ginkgo biloba products for better memory assume they are benefiting from ancient Chinese medical wisdom. Not at all, said Del Tredici: “It all began in a board room in Germany in the mid 1960s. The ancient ‘doctrine of signatures’ says that because a walnut looks like a brain, it must be good for the brain. By extension, if a Ginkgo lives ‘forever,’ it must be good for promoting long life.” The German firm Schwabe Pharmaceutical and a French subsidiary developed ginkgo-leaf extract into one of the blockbuster herbal medicines. Early in vitro research on the extract was promising—the substance appeared to promote blood flow. Said Del Tredici, “The rest is history. Ginkgo has become a hot commodity in the twenty-first century, a big cash cow” with annual sales topping $500 million.

Del Tredici found himself involved in this world soon after his first China trip. In early 1990, he flew down to Sumter, South Carolina, to see for himself a 1,000-acre ginkgo plantation with 10 million waist-high trees established in 1982 by the French Schwabe subsidiary. “I met the Swiss agronomist,” recalled Del Tredici, “and asked him if the trees were producing basal chichi. He said not at all. The whole operation was mechanized. They stripped the leaves off these plants in the summer and then they ran a chipper over them. They sprouted out the following spring. I knew the trees must be stressed, and that’s when ginkgos start producing basal chichi. So I proposed we get some shovels and dig down and see. To their amazement, there were all these chichi producing vigorous young shoots.”

So began Del Tredici’s decade as a consultant working for the French subsidiary manipulating either the quantity or the quality of those ginkgo leaves. “How the plants affected people’s physiology,” he said, “that was not my world.” In 2003, Schwabe provided Ginkgo biloba for five-year controlled trials in the United States, to see if the leaf extract proved helpful for memory loss. The 2008 and 2009 studies, Del Tredici said, “showed no significanteffect by ginkgo-leaf extract in patients suffering from dementia or memory problems.” 

Read more articles by Jill Jonnes

You might also like

In Sermon, Garber Urges Harvard Community to ‘Defend and Protect’ Institutions

Harvard’s president uses traditional Memorial Church address to encourage divergent views.

A New Narrative of Civil Rights

Political philosopher Brandon Terry’s vision of racial progress

This Astronomer is Sounding a Warning on 'Space Junk'

As debris accumulates in low Earth orbit, the danger of destructive collisions continues to rise.

Most popular

How MAGA Went Mainstream at Harvard

Trump, TikTok, and the pandemic are reshaping Gen Z politics.

Free Speech, the Bomb—and Donald Trump

A Harvard cardiologist on the unlikely alliances that shaped a global movement to prevent nuclear war

Explore More From Current Issue

John Goldberg

Harvard in the News

University layoffs, professors in court, and a new Law School dean

Illustration of scientists injecting large syringe with mitochondria into human heart.

Do Mitochondria Hold the Power to Heal?

From Alzheimer’s to cancer, this tiny organelle might expand treatment options. 

Illustrated world map showing people connected across countries with icons for ideas, research, and communication.

Why Harvard Needs International Students

An ed school professor on why global challenges demand global experiences